Ansbert Gadicke, Director at Chiasma, holds ― shares in Chiasma (Ticker: CHMA), holds 0.00 shares in TCR2 Therapeutics (Ticker: TCRR), holds 16.70M shares in AlloVir (Ticker: ALVR). Most recently, Ansbert Gadicke ― shares of Chiasma on ― for an estimated value of ―.
Ansbert Gadicke latest transaction was an Uninformative Buy of ―.
What was Ansbert Gadicke's most profitable transaction?
Ansbert Gadicke’s most profitable transaction was an Informative Sell of RPTX stock on March 15, 2021. The return on the trade was 57.20%.
What is Ansbert Gadicke's role in Chiasma?
Ansbert Gadicke's role in Chiasma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.